Development Information. Each Party will (a) provide the other Party with a copy of all submissions to be made by such Party to regulatory authorities prior to the date of such submissions in sufficient time to enable the other Party to comment on such submission, and (b) promptly provide the other Party with the results of all toxicology and pharmacology studies and clinical trials conducted by, or under the supervision of, such Party, with respect to the Licensed Products.
Appears in 2 contracts
Sources: Development and License Agreement (Transcend Therapeutics Inc), Development and License Agreement (Transcend Therapeutics Inc)